EC Healthcare's (HKG:2138) subsidiary, Jade Master International, completed the sale of its 51% stake in New Medical Centre to AIA Hong Kong Medical Services on Friday, a Monday Hong Kong bourse filing said.
The transaction was first announced in November 2024, with Jade Master agreeing to dispose of the majority stake for HK$437.6 million.
The company also completed the acquisition of a 40% stake in its unit, Hong Kong Medical Advanced Imaging (TST), as part of an internal reorganization within the group.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。